134 related articles for article (PubMed ID: 38445479)
21. Aging Effect, Reproducibility, and Test-Retest Reliability of a New Cerebral Amyloid Angiopathy MRI Severity Marker-Cerebrovascular Reactivity to Visual Stimulation.
van Dijk SE; Lak J; Drenth N; Hafkemeijer A; Rombouts SARB; van der Grond J; van Rooden S
J Magn Reson Imaging; 2023 Mar; 57(3):909-915. PubMed ID: 35876045
[TBL] [Abstract][Full Text] [Related]
22. Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy.
Kaushik K; de Kort AM; van Dort R; van der Zwet RGJ; Siegerink B; Voigt S; van Zwet EW; van der Plas MC; Koemans EA; Rasing I; Kessels RPC; Middelkoop HAM; Schreuder FHBM; Klijn CJM; Verbeek MM; Terwindt GM; van Etten ES; Wermer MJH
Alzheimers Res Ther; 2024 Apr; 16(1):74. PubMed ID: 38582898
[TBL] [Abstract][Full Text] [Related]
23. Centrum Semiovale Perivascular Space and Amyloid Deposition in Spontaneous Intracerebral Hemorrhage.
Tsai HH; Pasi M; Tsai LK; Huang CC; Chen YF; Lee BC; Yen RF; Gurol ME; Jeng JS
Stroke; 2021 Jul; 52(7):2356-2362. PubMed ID: 33874751
[TBL] [Abstract][Full Text] [Related]
24. MRI for in vivo diagnosis of cerebral amyloid angiopathy: Tailoring artifacts to image hemorrhagic biomarkers.
Boulouis G; Edjlali-Goujon M; Moulin S; Ben Hassen W; Naggara O; Oppenheim C; Cordonnier C
Rev Neurol (Paris); 2017 Nov; 173(9):554-561. PubMed ID: 28987481
[TBL] [Abstract][Full Text] [Related]
25. Brain hemorrhage on 24h-CT and functional outcome in stroke patients with cerebral amyloid angiopathy features on pre-thrombolysis MRI treated with intravenous thrombolysis: A case series.
Leonte A; Laurent-Chabalier S; Wacongne A; Parvu T; Hackius M; Thouvenot E; Renard D
J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106907. PubMed ID: 36442282
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis.
Malhotra K; Theodorou A; Katsanos AH; Zompola C; Shoamanesh A; Boviatsis E; Paraskevas GP; Spilioti M; Cordonnier C; Werring DJ; Alexandrov AV; Tsivgoulis G
Stroke; 2022 Jun; 53(6):1944-1953. PubMed ID: 35264008
[TBL] [Abstract][Full Text] [Related]
27. Microbleeds on MRI are associated with microinfarcts on autopsy in cerebral amyloid angiopathy.
Lauer A; van Veluw SJ; William CM; Charidimou A; Roongpiboonsopit D; Vashkevich A; Ayres A; Martinez-Ramirez S; Gurol EM; Biessels GJ; Frosch M; Greenberg SM; Viswanathan A
Neurology; 2016 Oct; 87(14):1488-1492. PubMed ID: 27613583
[TBL] [Abstract][Full Text] [Related]
28. Sex Differences in Onset and Progression of Cerebral Amyloid Angiopathy.
Koemans EA; Castello JP; Rasing I; Abramson JR; Voigt S; Perosa V; van Harten TW; van Zwet EW; Terwindt GM; Gurol ME; Rosand J; Greenberg SM; van Walderveen MAA; Biffi A; Viswanathan A; Wermer MJH
Stroke; 2023 Feb; 54(2):306-314. PubMed ID: 36689586
[TBL] [Abstract][Full Text] [Related]
29. Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.
Renard D; Tatu L; Collombier L; Wacongne A; Ayrignac X; Charif M; Boukriche Y; Chiper L; Fourcade G; Azakri S; Gaillard N; Mercier E; Lehmann S; Thouvenot E
J Alzheimers Dis; 2018; 64(4):1113-1121. PubMed ID: 30010128
[TBL] [Abstract][Full Text] [Related]
30. Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial.
Voigt S; Koemans EA; Rasing I; van Etten ES; Terwindt GM; Baas F; Kaushik K; van Es ACGM; van Buchem MA; van Osch MJP; van Walderveen MAA; Klijn CJM; Verbeek MM; van der Weerd L; Wermer MJH
Trials; 2023 Jun; 24(1):378. PubMed ID: 37277877
[TBL] [Abstract][Full Text] [Related]
31. Innovative Magnetic Resonance Imaging Markers of Hereditary Cerebral Amyloid Angiopathy at 7 Tesla.
Koemans EA; van Etten ES; van Opstal AM; Labadie G; Terwindt GM; Wermer MJH; Webb AG; Gurol EM; Greenberg SM; van Buchem MA; van der Grond J; van Rooden S
Stroke; 2018 Jun; 49(6):1518-1520. PubMed ID: 29695466
[TBL] [Abstract][Full Text] [Related]
32. Hemorrhage recurrence risk factors in cerebral amyloid angiopathy: Comparative analysis of the overall small vessel disease severity score versus individual neuroimaging markers.
Boulouis G; Charidimou A; Pasi M; Roongpiboonsopit D; Xiong L; Auriel E; van Etten ES; Martinez-Ramirez S; Ayres A; Vashkevich A; Schwab KM; Rosand J; Goldstein JN; Gurol ME; Greenberg SM; Viswanathan A
J Neurol Sci; 2017 Sep; 380():64-67. PubMed ID: 28870591
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal decrease in blood oxygenation level dependent response in cerebral amyloid angiopathy.
Switzer AR; McCreary C; Batool S; Stafford RB; Frayne R; Goodyear BG; Smith EE
Neuroimage Clin; 2016; 11():461-467. PubMed ID: 27104140
[TBL] [Abstract][Full Text] [Related]
34. [Pre-critical MRI findings of an Alzheimer's disease patient with pathologically proven cerebral amyloid angiopathy related lobar hemorrhage].
Nonaka T; Yakushiji Y; Ide T; Ito H; Kawamoto K; Hara H
Rinsho Shinkeigaku; 2016 May; 56(5):338-43. PubMed ID: 27151228
[TBL] [Abstract][Full Text] [Related]
35. Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population.
van Rooden S; van der Grond J; van den Boom R; Haan J; Linn J; Greenberg SM; van Buchem MA
Stroke; 2009 Sep; 40(9):3022-7. PubMed ID: 19556530
[TBL] [Abstract][Full Text] [Related]
36. Intracerebral Hemorrhage Recurrence in Patients with and without Cerebral Amyloid Angiopathy.
Pinho J; Araújo JM; Costa AS; Silva F; Francisco A; Quintas-Neves M; Soares-Fernandes J; Ferreira C; Oliveira TG
Cerebrovasc Dis Extra; 2021; 11(1):15-21. PubMed ID: 33503633
[TBL] [Abstract][Full Text] [Related]
37. Multiple Approaches to Diffusion Magnetic Resonance Imaging in Hereditary Cerebral Amyloid Angiopathy Mutation Carriers.
Schouten TM; de Vos F; van Rooden S; Bouts MJRJ; van Opstal AM; Feis RA; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; de Rooij M; Rombouts SARB; van der Grond J
J Am Heart Assoc; 2019 Feb; 8(3):e011288. PubMed ID: 30717612
[TBL] [Abstract][Full Text] [Related]
38. Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.
de Kort AM; Kuiperij HB; Jäkel L; Kersten I; Rasing I; van Etten ES; van Rooden S; van Osch MJP; Wermer MJH; Terwindt GM; Schreuder FHBM; Klijn CJM; Verbeek MM
Alzheimers Res Ther; 2023 Jun; 15(1):102. PubMed ID: 37270536
[TBL] [Abstract][Full Text] [Related]
39. Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage.
Xiong L; Boulouis G; Charidimou A; Roongpiboonsopit D; Jessel MJ; Pasi M; Reijmer YD; Fotiadis P; Ayres A; Merrill E; Schwab K; Blacker D; Gurol ME; Greenberg SM; Viswanathan A
J Cereb Blood Flow Metab; 2018 Feb; 38(2):241-249. PubMed ID: 28318355
[TBL] [Abstract][Full Text] [Related]
40. MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy.
Charidimou A; Boulouis G; Pasi M; Auriel E; van Etten ES; Haley K; Ayres A; Schwab KM; Martinez-Ramirez S; Goldstein JN; Rosand J; Viswanathan A; Greenberg SM; Gurol ME
Neurology; 2017 Mar; 88(12):1157-1164. PubMed ID: 28228568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
